Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study-Reference-Cited by-同舟云学术

Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study

Published:2016-09 Issue:9 Volume:34 Page:415.e13-415.e19
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Lazzeri Massimo,Lughezzani Giovanni^ORCID,Haese Alexander,McNicholas Thomas,de la Taille Alexandre,Buffi Nicolò Maria,Cardone Pasquale,Hurle Rodolfo,Casale Paolo,Bini Vittorio,Redorta Joan Palou,Graefen Markus,Guazzoni Giorgio

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference26 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J Clin,2013

2. Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine;Hedelin;Scand J Urol Nephrol,2005

3. Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study;Simardi;Urology,2004

4. Variability of repeated serum prostate-specific antigen (PSA) measurements within less than 90 days in a well-defined patient population;Roehrborn;Urology,1996

5. Variation in prostate specific antigen results from 2 different assay platforms: clinical impact on 2304 patients undergoing prostate cancer screening;Link;J Urol,2004

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Radiological Factors for Predicting Clinically Significant Prostate Cancer in Biopsy-Naive Patients With PI-RADS 3 Lesions;Technology in Cancer Research & Treatment;2024-01

2. Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?;Clinica Chimica Acta;2023-03

3. Molecular Biomarkers for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis;European Urology Open Science;2022-12

4. Lesion Volume in a Bi- or Multivariate Prediction Model for the Management of PI-RADS v2.1 Score 3 Category Lesions;Türk Üroloji Dergisi/Turkish Journal of Urology;2022-07-28

5. Prostate health index (PHI) as a reliable biomarker for prostate cancer: a systematic review and meta-analysis;Clinical Chemistry and Laboratory Medicine (CCLM);2022-05-16